MARCHETTI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 5.687
AS - Asia 2.930
EU - Europa 1.453
SA - Sud America 521
AF - Africa 75
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.670
Nazione #
US - Stati Uniti d'America 5.550
SG - Singapore 1.124
CN - Cina 738
BR - Brasile 408
VN - Vietnam 372
IT - Italia 307
UA - Ucraina 248
HK - Hong Kong 244
DE - Germania 208
GB - Regno Unito 177
TR - Turchia 122
FI - Finlandia 106
FR - Francia 101
RU - Federazione Russa 73
CA - Canada 71
JP - Giappone 70
IN - India 60
SE - Svezia 58
BD - Bangladesh 53
MX - Messico 50
PL - Polonia 45
AR - Argentina 39
ID - Indonesia 34
IQ - Iraq 28
NL - Olanda 27
ZA - Sudafrica 24
CO - Colombia 17
ES - Italia 16
EC - Ecuador 15
LT - Lituania 15
CZ - Repubblica Ceca 14
VE - Venezuela 13
BE - Belgio 12
AT - Austria 11
MA - Marocco 11
PK - Pakistan 10
SA - Arabia Saudita 10
CL - Cile 9
EG - Egitto 8
PH - Filippine 8
TN - Tunisia 8
UZ - Uzbekistan 8
IE - Irlanda 7
PE - Perù 7
TW - Taiwan 7
PY - Paraguay 6
CH - Svizzera 5
IR - Iran 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
BO - Bolivia 4
CR - Costa Rica 4
ET - Etiopia 4
KR - Corea 4
SY - Repubblica araba siriana 4
DZ - Algeria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
RO - Romania 3
UY - Uruguay 3
AU - Australia 2
AZ - Azerbaigian 2
DK - Danimarca 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
LY - Libia 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
UG - Uganda 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SI - Slovenia 1
Totale 10.665
Città #
Singapore 735
Ashburn 695
Fairfield 555
Woodbridge 436
San Jose 348
Houston 323
Beijing 269
Chandler 251
Santa Clara 251
Jacksonville 242
Hong Kong 236
Seattle 218
Ann Arbor 212
Cambridge 198
Wilmington 180
Ho Chi Minh City 122
New York 104
Los Angeles 96
Hanoi 92
Nanjing 85
Ferrara 82
Izmir 76
Tokyo 69
Dallas 64
San Diego 59
Munich 57
São Paulo 56
Princeton 54
Lauterbourg 52
Council Bluffs 50
Warsaw 42
Boardman 41
London 40
Shanghai 38
The Dalles 37
Mexico City 35
Orem 33
Helsinki 30
Chicago 27
Turku 25
Hefei 23
Brooklyn 22
Frankfurt am Main 22
Milan 22
Nanchang 22
Atlanta 20
Chennai 20
Da Nang 20
Shenyang 20
Addison 19
Jakarta 19
Montreal 19
Hebei 18
Tianjin 18
Toronto 18
Denver 17
San Francisco 16
Bologna 15
Rio de Janeiro 15
Stockholm 15
Baghdad 14
Boston 14
Bremen 14
Buffalo 14
Phoenix 14
Haiphong 13
Amsterdam 12
Brussels 12
Moscow 12
Philadelphia 12
Johannesburg 11
Mumbai 11
Poplar 11
Manchester 10
Verona 10
Washington 10
Ankara 8
Biên Hòa 8
Changsha 8
Falkenstein 8
Leawood 8
Norwalk 8
Olomouc 8
San Mateo 8
Tashkent 8
Hải Dương 7
Kunming 7
Medellín 7
Ottawa 7
Paris 7
Rome 7
Salt Lake City 7
Taipei 7
Turin 7
Auburn Hills 6
Belo Horizonte 6
Brasília 6
Charlotte 6
Dhaka 6
Dublin 6
Totale 7.360
Nome #
4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors 291
Conjugation of LasR Quorum-Sensing Inhibitors with Ciprofloxacin Decreases the Antibiotic Tolerance of P-aeruginosa Clinical Strains 291
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 288
Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor 271
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives. 264
4-[(4-Methylphenyl)sulfonyl]-1-(triphenylphosphoranylidene)-2-butanone as a convenient precursor for a new formal synthesis of KDO 252
Design, synthesis and biological evaluation of novel stilbene-based antitumor agents 244
2-Bromoamides as Synthons for Pseudopeptides Containing Aminodicarboxy Units 241
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 238
2-Aminoamides and Pseudopeptides Carrying an Amino Group Common to two Residues 233
Hemiasterlin derivative (R)(S)(S)-BF65 and Akt inhibitor MK-2206 synergistically inhibit SKOV3 ovarian cancer cell growth 229
4-[(4 '-methylphenyl)sulfonyl]-1-(triphenylphosphoranylidene)-2-butanone as a new four-carbon synthon for substituted divinyl ketones 228
D-(-)-Quinic acid: a chiron store for natural product synthesis 228
Development of water soluble derivatives of cis-3, 4', 5-trimethoxy-3'- aminostilbene for optimization and use in cancer therapy 224
Design of Nanosystems for the Delivery of Quorum Sensing Inhibitors: A Preliminary Study 220
4-[(4-Methylphenyl)sulfonyl]-1-(triphenylphosphoranylidene)-2-butanone and its dianion as versatile tools in organic synthesis 219
2-Bromoamides. Stereocontrolled Substitution and Application to the Synthesis of Compounds of Biological Interest 214
Antitumor effects of curcumin and structurally β-diketone modified analogs on multidrug resistant cancer cells 209
Diastereoselective synthesis of beta-amino-alpha-hydroxy phosphonates via oxazaborolidine catalyzed reduction of beta-phthalimido-alpha-keto phosphonates 207
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities 204
Synthesis of 2,5-disubstituted pyrroles and pyrrolidines by intramolecular cyclization of 6-amino-3-keto sulfones 200
Dihydroartemisinin-Bile Acid Hybridization as an Effective Approach to Enhance Dihydroartemisinin Anticancer Activity 196
Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a γδ-T lymphocytes-mediated activation mechanism 192
Enantioselective reactions of 2-bromopropanamides with primary secondary or tertiary amines. Synthesis of some alaninamides. 189
Synthetic Approach to non-Isosteric Peptidomimetics Related to Human Endothelin 183
Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib 178
Base-Promoted Cyclocoupling Reaction of 2-Bromopropanamides and 2-Bromoacetamides with DMF 174
Enantioselective approach to tropane skeleton: Synthesis of (1S,5S,6R)-6-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-one 170
Synthesis and NLRP3-Inflammasome Inhibitory Activity of the Naturally Occurring Velutone F and of Its Non-Natural Regioisomeric Chalconoids 167
Characterization of Stable Pyrazole Derivatives of Curcumin with Improved Cytotoxicity on Osteosarcoma Cell Lines 166
Solid-phase synthesis of indolizidine and quinolizidine derivatives 164
Versatile Synthesis of New Cytotoxic Agents Structurally Related to Emiasterlins 163
Polymer-bound 4-benzylsulfonyl-1-triphenylphosphoranylidene-2-butanone as a tool for the solid-phase synthesis of substituted piperidin-4-one derivatives 162
A Mass Spectroscopy Study on Some 2-Bromopropananilides Derivatives 158
Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2 153
Stilbene-based anticancer agents: Resveratrol analogues active toward HL60 leukemic cells wit a non-specific phase mechanism 152
Enantioselective formal synthesis of (-)-ovalicin using quinic acid as a chiral template 151
Un nuovo sintone a quattro atomi di carbonio come equivalente sintetico di divinil chetoni sostituiti 150
STEREOSELECTIVE SUBSTITUTION IN 2-BROMO AMIDES IN THE PRESENCE OF AG+ OR AG2O 148
Single Diastereomeric Desaminotyrosylalanyl Tetra- and Heptapeptides with Opioid Antagonistic Activity 147
Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells 147
Evidence for exo-anomeric stereoelectronic effect in cyclic orthoester aminals from X-ray structural data. Crystal structures of three 2-amino-1,3-oxazolin-4-one derivatives. 142
Critical surveys covering the year 1999: total synthesis of natural products 138
Stereoselective synthesis of neutral and cationic 2-heterocyclically substituted propanamides 137
Stereoselective synthesis of N,N-diaryl-2,5-dioxopiperazines from homochiral or racemic 2-bromopropananilides 135
From (-)-quinic acid to 8-azabicyclo[3.2.1]octane framework: Preparation of an enantiopure tropan-6 alpha-ol 135
Ether-amides and Glycoside-amides from 2-Bromoisobutyramides and Saccharides bearing a Free Primary, Secondary or Anomeric Alcoholic Group. 132
Synthesis and biological evaluation of novel rhodanine-based structures with antiviral activity towards HHV-6 virus 131
The Fascinating Chemistry of α-Haloamides 129
null 125
null 125
Anticancer Activity and Molecular Mechanisms of an Ursodeoxycholic Acid Methyl Ester-Dihydroartemisinin Hybrid via a Triazole Linkage in Hepatocellular Carcinoma Cells 124
Stereoselective formation of glycoconjugated lactamides from chiral 2-Bromopropanamides. 123
Evidence of the exo-Anomeric Stereoelectronic Effect in Orthoester Aminals from X-Ray Structural Data. Crystal Structures of Three 2-Amino-1,3-oxazolin-4-one derivatives 123
Structure-Activity Relationship in the Mutagenic Effect of Chiral or Racemic 2-Bromo-2-propanamides on Salmonella typhimurium 121
Synthesis and biological activity of a novel class nicotinic acetylcholine receptors (nAChRs) ligands structurally related to anatoxin-a. 117
Reactions of 2-bromopropanamides with conjugated bases of representative beta-dicarbonyl compounds. Synthesis of 2,5-dioxopyrrolidines and oxazolidine-4-ones 111
Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90. 107
Sometimes, the Least Demanding Solution Is the Most Suitable: A Careful Survey of NMR Spectra of a Phosphonium Salt Accounted for Its “Unusual Wittig Reaction” 93
Multi-Step Synthesis of Chimeric Nutlin–DCA Compounds Targeting Dual Pathways for Treatment of Cancer 83
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial 83
Synthesis of a Cannabidiol Precursor: Experimental Challenges and DFT Insights into β-Elimination Barriers 39
Totale 10.758
Categoria #
all - tutte 45.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.223
Totale 47.917


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 0 41
2021/2022579 29 70 45 21 35 18 24 33 15 36 48 205
2022/2023580 57 45 18 73 93 77 17 67 79 7 31 16
2023/2024367 28 41 26 9 29 89 17 20 10 10 12 76
2024/20251.359 33 27 123 80 158 107 24 59 233 136 207 172
2025/20264.518 464 232 339 575 688 331 490 276 416 495 166 46
Totale 10.758